Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

ANVS

Annovis Bio, Inc.

CIK 0001477845 · NYSE

NYSEHealth CarePharmaceutical Preparations
$1.82
↑ 0.03 (1.68%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Fundamentals, Ownership, Options; Risks: Technicals

Key stats

Market Cap
$77.43M
P/E Ratio
-1.56
EPS
-1.40
Dividend Yield
Not covered
52W Position
7%
Beta
1.85

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
-18.20
P/S
Not covered
EV/Revenue
Not covered
ROE
1164.0%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 7%
$1.54$5.50

Latest Financials

2025-12-31 FY
Revenue
$0.00
Net Income
-$28.85M
Total Assets
$21.08M
Free Cash Flow
–

Recent news